Article info

Download PDFPDF
Payer decision-making with limited comparative and cost effectiveness data: the case of new pharmacological treatments for gout
  1. Correspondence to Laura T Pizzi
    , Jefferson School of Pharmacy, 130 South 9th Street, Philadelphia, PN 19107, USA; laura.pizzi{at}jefferson.edu

Citation

Meltzer M, Pizzi LT, Jutkowitz E
Payer decision-making with limited comparative and cost effectiveness data: the case of new pharmacological treatments for gout

Publication history

  • First published February 18, 2012.
Online issue publication 
July 28, 2012

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.